Novel nucleosides as potent influenza viral inhibitors

Novel nucleosides were synthesized from di benzoyl fluoro lactone ( 1) and evaluated their anti-influenza viral activity. Compound ( 18c) showed the best antiviral activity among the compounds synthesized. Influenza virus infection constitutes a significant health problem in need of more effective t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2010-09, Vol.18 (17), p.6329-6339
Hauptverfasser: Vedula, Manohar Sharma, Jennepalli, Sreenu, Aryasomayajula, Ratnakar, Rondla, Subhash Reddy, Musku, Madanmohan Reddy, Kura, Rathnakar Reddy, Bandi, Parthasaradhi Reddy
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6339
container_issue 17
container_start_page 6329
container_title Bioorganic & medicinal chemistry
container_volume 18
creator Vedula, Manohar Sharma
Jennepalli, Sreenu
Aryasomayajula, Ratnakar
Rondla, Subhash Reddy
Musku, Madanmohan Reddy
Kura, Rathnakar Reddy
Bandi, Parthasaradhi Reddy
description Novel nucleosides were synthesized from di benzoyl fluoro lactone ( 1) and evaluated their anti-influenza viral activity. Compound ( 18c) showed the best antiviral activity among the compounds synthesized. Influenza virus infection constitutes a significant health problem in need of more effective therapies. We have recently identified ((2 R,3 S,4 R,5 R)-3-acetoxy-5-(4-benzamido-2-oxopyrimidin-1(2 H)-yl)-4-fluoro-3,4-dimethyl-tetrahydrofuran-2-yl) methyl benzoate ( 18c) as a potent influenza virus inhibitor. We now here report the synthesis and evaluation of a series of C-3′ modified ribose nucleosides. These novel compounds were prepared, primarily by taking known ((2 R,3 R,4 R)-3-benzoyloxy-4-fluoro-4-methyl-5-oxo-tetrahydrofuran-2-yl)methyl benzoate ( 1) and converting it in to C-3 keto sugar ( 7), reacting C-3 keto group with methyl magnesium bromide, followed by coupling these sugars with purine and pyrimidine bases. Anti influenza viral activity was determined by screening against both A and B viral strains.
doi_str_mv 10.1016/j.bmc.2010.07.017
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_749002592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089610006607</els_id><sourcerecordid>749002592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-749b85fe2f4f7ebc205cac2e9f8ca983154182407ac8a9fb06980ce23ece74eb3</originalsourceid><addsrcrecordid>eNp9kEtP4zAURi3ECMrjB7BB2SBW6Vw7TmyLFap4SWhmM7O2nNtr4SpNip1UGn79GLXAjtXVJ537OoxdcJhz4M3P1bxd41xAzqDmwNUBm3HZyLKqDD9kMzCNLkGb5pidpLQCACENP2LHAholK8VnrPk1bKkr-gk7GlJYUipcKjbDSP1YhN53E_VvrtiG6LqcX0IbxiGmM_bDuy7R-b6esr_3d38Wj-Xz74enxe1ziZUWY6mkaXXtSXjpFbUooEaHgozX6IyueC25FhKUQ-2Mb6ExGpBERUhKUludsuvd3E0cXidKo12HhNR1rqdhSjYvyE_VRmSS70iMQ0qRvN3EsHbxn-Vg323Zlc227LstC8pmW7nncj99ate0_Oz40JOBqz3gErrOR9djSF9cxU0NjczczY6j7GIbKNqEgXqkZYiEo10O4Zsz_gNpp4dD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>749002592</pqid></control><display><type>article</type><title>Novel nucleosides as potent influenza viral inhibitors</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Vedula, Manohar Sharma ; Jennepalli, Sreenu ; Aryasomayajula, Ratnakar ; Rondla, Subhash Reddy ; Musku, Madanmohan Reddy ; Kura, Rathnakar Reddy ; Bandi, Parthasaradhi Reddy</creator><creatorcontrib>Vedula, Manohar Sharma ; Jennepalli, Sreenu ; Aryasomayajula, Ratnakar ; Rondla, Subhash Reddy ; Musku, Madanmohan Reddy ; Kura, Rathnakar Reddy ; Bandi, Parthasaradhi Reddy</creatorcontrib><description>Novel nucleosides were synthesized from di benzoyl fluoro lactone ( 1) and evaluated their anti-influenza viral activity. Compound ( 18c) showed the best antiviral activity among the compounds synthesized. Influenza virus infection constitutes a significant health problem in need of more effective therapies. We have recently identified ((2 R,3 S,4 R,5 R)-3-acetoxy-5-(4-benzamido-2-oxopyrimidin-1(2 H)-yl)-4-fluoro-3,4-dimethyl-tetrahydrofuran-2-yl) methyl benzoate ( 18c) as a potent influenza virus inhibitor. We now here report the synthesis and evaluation of a series of C-3′ modified ribose nucleosides. These novel compounds were prepared, primarily by taking known ((2 R,3 R,4 R)-3-benzoyloxy-4-fluoro-4-methyl-5-oxo-tetrahydrofuran-2-yl)methyl benzoate ( 1) and converting it in to C-3 keto sugar ( 7), reacting C-3 keto group with methyl magnesium bromide, followed by coupling these sugars with purine and pyrimidine bases. Anti influenza viral activity was determined by screening against both A and B viral strains.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2010.07.017</identifier><identifier>PMID: 20674371</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Antiviral Agents - chemical synthesis ; Antiviral Agents - pharmacology ; Biological and medical sciences ; Cell Line ; Dogs ; Humans ; Influenza A virus - drug effects ; Influenza B virus - drug effects ; Influenza virus ; Influenza, Human - drug therapy ; Influenza, Human - virology ; Medical sciences ; Nucleosides ; Pharmacology. Drug treatments ; Purine Nucleosides - chemistry ; Purine Nucleosides - pharmacology ; Pyrimidine Nucleosides - chemical synthesis ; Pyrimidine Nucleosides - pharmacology ; SAR ; Structure-Activity Relationship</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2010-09, Vol.18 (17), p.6329-6339</ispartof><rights>2010 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-749b85fe2f4f7ebc205cac2e9f8ca983154182407ac8a9fb06980ce23ece74eb3</citedby><cites>FETCH-LOGICAL-c382t-749b85fe2f4f7ebc205cac2e9f8ca983154182407ac8a9fb06980ce23ece74eb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0968089610006607$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23195064$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20674371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vedula, Manohar Sharma</creatorcontrib><creatorcontrib>Jennepalli, Sreenu</creatorcontrib><creatorcontrib>Aryasomayajula, Ratnakar</creatorcontrib><creatorcontrib>Rondla, Subhash Reddy</creatorcontrib><creatorcontrib>Musku, Madanmohan Reddy</creatorcontrib><creatorcontrib>Kura, Rathnakar Reddy</creatorcontrib><creatorcontrib>Bandi, Parthasaradhi Reddy</creatorcontrib><title>Novel nucleosides as potent influenza viral inhibitors</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>Novel nucleosides were synthesized from di benzoyl fluoro lactone ( 1) and evaluated their anti-influenza viral activity. Compound ( 18c) showed the best antiviral activity among the compounds synthesized. Influenza virus infection constitutes a significant health problem in need of more effective therapies. We have recently identified ((2 R,3 S,4 R,5 R)-3-acetoxy-5-(4-benzamido-2-oxopyrimidin-1(2 H)-yl)-4-fluoro-3,4-dimethyl-tetrahydrofuran-2-yl) methyl benzoate ( 18c) as a potent influenza virus inhibitor. We now here report the synthesis and evaluation of a series of C-3′ modified ribose nucleosides. These novel compounds were prepared, primarily by taking known ((2 R,3 R,4 R)-3-benzoyloxy-4-fluoro-4-methyl-5-oxo-tetrahydrofuran-2-yl)methyl benzoate ( 1) and converting it in to C-3 keto sugar ( 7), reacting C-3 keto group with methyl magnesium bromide, followed by coupling these sugars with purine and pyrimidine bases. Anti influenza viral activity was determined by screening against both A and B viral strains.</description><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - chemical synthesis</subject><subject>Antiviral Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Dogs</subject><subject>Humans</subject><subject>Influenza A virus - drug effects</subject><subject>Influenza B virus - drug effects</subject><subject>Influenza virus</subject><subject>Influenza, Human - drug therapy</subject><subject>Influenza, Human - virology</subject><subject>Medical sciences</subject><subject>Nucleosides</subject><subject>Pharmacology. Drug treatments</subject><subject>Purine Nucleosides - chemistry</subject><subject>Purine Nucleosides - pharmacology</subject><subject>Pyrimidine Nucleosides - chemical synthesis</subject><subject>Pyrimidine Nucleosides - pharmacology</subject><subject>SAR</subject><subject>Structure-Activity Relationship</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtP4zAURi3ECMrjB7BB2SBW6Vw7TmyLFap4SWhmM7O2nNtr4SpNip1UGn79GLXAjtXVJ537OoxdcJhz4M3P1bxd41xAzqDmwNUBm3HZyLKqDD9kMzCNLkGb5pidpLQCACENP2LHAholK8VnrPk1bKkr-gk7GlJYUipcKjbDSP1YhN53E_VvrtiG6LqcX0IbxiGmM_bDuy7R-b6esr_3d38Wj-Xz74enxe1ziZUWY6mkaXXtSXjpFbUooEaHgozX6IyueC25FhKUQ-2Mb6ExGpBERUhKUludsuvd3E0cXidKo12HhNR1rqdhSjYvyE_VRmSS70iMQ0qRvN3EsHbxn-Vg323Zlc227LstC8pmW7nncj99ate0_Oz40JOBqz3gErrOR9djSF9cxU0NjczczY6j7GIbKNqEgXqkZYiEo10O4Zsz_gNpp4dD</recordid><startdate>20100901</startdate><enddate>20100901</enddate><creator>Vedula, Manohar Sharma</creator><creator>Jennepalli, Sreenu</creator><creator>Aryasomayajula, Ratnakar</creator><creator>Rondla, Subhash Reddy</creator><creator>Musku, Madanmohan Reddy</creator><creator>Kura, Rathnakar Reddy</creator><creator>Bandi, Parthasaradhi Reddy</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100901</creationdate><title>Novel nucleosides as potent influenza viral inhibitors</title><author>Vedula, Manohar Sharma ; Jennepalli, Sreenu ; Aryasomayajula, Ratnakar ; Rondla, Subhash Reddy ; Musku, Madanmohan Reddy ; Kura, Rathnakar Reddy ; Bandi, Parthasaradhi Reddy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-749b85fe2f4f7ebc205cac2e9f8ca983154182407ac8a9fb06980ce23ece74eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - chemical synthesis</topic><topic>Antiviral Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Dogs</topic><topic>Humans</topic><topic>Influenza A virus - drug effects</topic><topic>Influenza B virus - drug effects</topic><topic>Influenza virus</topic><topic>Influenza, Human - drug therapy</topic><topic>Influenza, Human - virology</topic><topic>Medical sciences</topic><topic>Nucleosides</topic><topic>Pharmacology. Drug treatments</topic><topic>Purine Nucleosides - chemistry</topic><topic>Purine Nucleosides - pharmacology</topic><topic>Pyrimidine Nucleosides - chemical synthesis</topic><topic>Pyrimidine Nucleosides - pharmacology</topic><topic>SAR</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vedula, Manohar Sharma</creatorcontrib><creatorcontrib>Jennepalli, Sreenu</creatorcontrib><creatorcontrib>Aryasomayajula, Ratnakar</creatorcontrib><creatorcontrib>Rondla, Subhash Reddy</creatorcontrib><creatorcontrib>Musku, Madanmohan Reddy</creatorcontrib><creatorcontrib>Kura, Rathnakar Reddy</creatorcontrib><creatorcontrib>Bandi, Parthasaradhi Reddy</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vedula, Manohar Sharma</au><au>Jennepalli, Sreenu</au><au>Aryasomayajula, Ratnakar</au><au>Rondla, Subhash Reddy</au><au>Musku, Madanmohan Reddy</au><au>Kura, Rathnakar Reddy</au><au>Bandi, Parthasaradhi Reddy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel nucleosides as potent influenza viral inhibitors</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2010-09-01</date><risdate>2010</risdate><volume>18</volume><issue>17</issue><spage>6329</spage><epage>6339</epage><pages>6329-6339</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>Novel nucleosides were synthesized from di benzoyl fluoro lactone ( 1) and evaluated their anti-influenza viral activity. Compound ( 18c) showed the best antiviral activity among the compounds synthesized. Influenza virus infection constitutes a significant health problem in need of more effective therapies. We have recently identified ((2 R,3 S,4 R,5 R)-3-acetoxy-5-(4-benzamido-2-oxopyrimidin-1(2 H)-yl)-4-fluoro-3,4-dimethyl-tetrahydrofuran-2-yl) methyl benzoate ( 18c) as a potent influenza virus inhibitor. We now here report the synthesis and evaluation of a series of C-3′ modified ribose nucleosides. These novel compounds were prepared, primarily by taking known ((2 R,3 R,4 R)-3-benzoyloxy-4-fluoro-4-methyl-5-oxo-tetrahydrofuran-2-yl)methyl benzoate ( 1) and converting it in to C-3 keto sugar ( 7), reacting C-3 keto group with methyl magnesium bromide, followed by coupling these sugars with purine and pyrimidine bases. Anti influenza viral activity was determined by screening against both A and B viral strains.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>20674371</pmid><doi>10.1016/j.bmc.2010.07.017</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2010-09, Vol.18 (17), p.6329-6339
issn 0968-0896
1464-3391
language eng
recordid cdi_proquest_miscellaneous_749002592
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Antiviral Agents - chemical synthesis
Antiviral Agents - pharmacology
Biological and medical sciences
Cell Line
Dogs
Humans
Influenza A virus - drug effects
Influenza B virus - drug effects
Influenza virus
Influenza, Human - drug therapy
Influenza, Human - virology
Medical sciences
Nucleosides
Pharmacology. Drug treatments
Purine Nucleosides - chemistry
Purine Nucleosides - pharmacology
Pyrimidine Nucleosides - chemical synthesis
Pyrimidine Nucleosides - pharmacology
SAR
Structure-Activity Relationship
title Novel nucleosides as potent influenza viral inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A48%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20nucleosides%20as%20potent%20influenza%20viral%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Vedula,%20Manohar%20Sharma&rft.date=2010-09-01&rft.volume=18&rft.issue=17&rft.spage=6329&rft.epage=6339&rft.pages=6329-6339&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2010.07.017&rft_dat=%3Cproquest_cross%3E749002592%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=749002592&rft_id=info:pmid/20674371&rft_els_id=S0968089610006607&rfr_iscdi=true